Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 22 member 13 (SLC22A13), also known as OAT10, is an anion antiporter primarily expressed in the kidneys and intestines. It mediates the transport of urate, orotate, and nicotinate in exchange for other anions, playing a crucial role in renal uric acid reabsorption and potentially affecting vitamin metabolism. Its involvement in uric acid transport makes it relevant to hyperuricemia and kidney stone formation.
Modulation of anion exchange and urate/orotate/nicotinate transport.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute Carrier Family 22 Member 13 (OAT10).